Rankin G O, Valentovic M A, Nicoll D W, Ball J G, Anestis D K, Wang R T, Brown P I
Department of Pharmacology, Marshall University School of Medicine, Huntington, West Virginia 25755-9310.
Toxicology. 1994 May 31;90(1-2):115-28. doi: 10.1016/0300-483x(94)90210-0.
Halogenated anilines and aminophenols are nephrotoxicants and hepatotoxicants in mammals. The purpose of this study was to determine the in vivo and in vitro nephrotoxic and hepatotoxic potential of 4-amino-2,6-dichlorophenol, a putative metabolite of 3,5-dichloroaniline. In the in vivo experiments, male Fischer 344 rats (four/group) were administered a single intraperitoneal (i.p.) injection of 4-amino-2,6-dichlorophenol (0.25, 0.38 or 0.50 mmol/kg) or vehicle (dimethylsulfoxide (DMSO), 1.0 ml/kg) and renal and hepatic function monitored for 48 h. Only minor changes in function or morphology were observed in the 0.25 mmol/kg treatment group. However, in the 0.38 mmol/kg treatment group evidence of both nephrotoxicity and hepatotoxicity were evident. Nephrotoxicity was characterized by increased proteinuria, glucosuria, hematuria, elevated blood urea nitrogen (BUN) concentration and kidney weight, decreased p-aminohippurate (PAH) accumulation and proximal tubular necrosis in the corticomedullary region of the kidney. Hepatotoxicity was characterized by elevated plasma alanine aminotransferase (ALT/GPT) activity and liver weight. Animals administered the 0.5 mmol/kg dose died within 24 h. In the in vitro experiments, the effect of 4-amino-2,6-dichlorophenol on organic ion accumulation, gluconeogenesis and lactate dehydrogenase (LDH) leakage was quantitated in liver and/or renal cortical slices. Organic anion accumulation was inhibited in renal cortical slices by 4-amino-2,6-dichlorophenol bath concentrations of 5 x 10(-6) M or higher, while organic cation uptake was decreased at 4-amino-2,6-dichlorophenol bath concentrations of 1 x 10(-5) M or greater. Renal and hepatic pyruvate-stimulated gluconeogenesis were inhibited and renal LDH leakage increased at 4-amino-2,6-dichlorophenol bath concentrations of 5 x 10(-5) M or greater. Increased LDH leakage from liver slices was not observed. These results demonstrate that 4-amino-2,6-dichlorophenol is a nephrotoxicant and hepatotoxicant in vivo and in vitro and that the kidney is more susceptible to 4-amino-2,6-dichlorophenol toxicity than the liver.
卤代苯胺和氨基酚对哺乳动物具有肾毒性和肝毒性。本研究的目的是确定4-氨基-2,6-二氯苯酚(3,5-二氯苯胺的一种假定代谢产物)在体内和体外的肾毒性和肝毒性潜力。在体内实验中,对雄性Fischer 344大鼠(每组4只)进行单次腹腔注射4-氨基-2,6-二氯苯酚(0.25、0.38或0.50 mmol/kg)或溶媒(二甲基亚砜(DMSO),1.0 ml/kg),并监测48小时的肾功能和肝功能。在0.25 mmol/kg治疗组中仅观察到功能或形态的轻微变化。然而,在0.38 mmol/kg治疗组中,肾毒性和肝毒性的证据均很明显。肾毒性的特征是蛋白尿、糖尿、血尿增加,血尿素氮(BUN)浓度和肾脏重量升高,对氨基马尿酸(PAH)蓄积减少以及肾皮质髓质区域近端肾小管坏死。肝毒性的特征是血浆丙氨酸转氨酶(ALT/GPT)活性和肝脏重量升高。给予0.5 mmol/kg剂量组的动物在24小时内死亡。在体外实验中,在肝脏和/或肾皮质切片中定量研究了4-氨基-2,6-二氯苯酚对有机离子蓄积、糖异生和乳酸脱氢酶(LDH)泄漏的影响。4-氨基-2,6-二氯苯酚浴液浓度为5×10(-6) M或更高时,肾皮质切片中的有机阴离子蓄积受到抑制,而4-氨基-2,6-二氯苯酚浴液浓度为1×10(-5) M或更高时,有机阳离子摄取减少。4-氨基-2,6-二氯苯酚浴液浓度为5×10(-5) M或更高时,肾和肝丙酮酸刺激的糖异生受到抑制,肾LDH泄漏增加。未观察到肝切片中LDH泄漏增加。这些结果表明,4-氨基-2,6-二氯苯酚在体内和体外均具有肾毒性和肝毒性,并且肾脏比肝脏对4-氨基-2,6-二氯苯酚的毒性更敏感。